Malignant pleural mesothelioma targeted proteomics signature from blood
Cerciello F, Choi M, Sinicropi-Yao SL, Lomeo K, Amann JM, Felley-Bosco E, Stahel RA, Robinson BW, Creaney J, Pass HI, Vitek O, Carbone DP. Verification of a blood based targeted proteomics signature for malignant pleural mesothelioma. Cancer Epidemiol Biomarkers Prev. 2020 Jul 30:cebp.0543.2020. doi: 10.1158/1055-9965.EPI-20-0543. Epub ahead of print. PMID: 32732250.
- Organism: Homo sapiens
- Instrument: Xevo TQ-S
- SpikeIn:
No
- Keywords:
mesothelioma, asbestos exposed, SRM
-
Lab head: David P. Carbone
Submitter: Ferdinando Cerciello
Targeted proteomics based blood biomarkers for malignant pleural mesothelioma cancer
SRM analysis of serum samples enriched for N-linked glycoproteins
Serum samples from patients affected by malignant pleural mesothelioma and cancer free asbestos exposed donors
Created on 4/9/20, 8:25 PM